←MRK · $149.06

Merck

MRK · Market open

$149.06

+0.98% today·exchange $148.83

exchange $148.83

Nov 24$95.58 – $155.99Sep 24

1D 1W 1M 1Y

News · Merck

These Dow Jones Stocks Buck Index's Dud Performance
Investor's Business Daily · just now
Inhibrx’s Cancer Drug Nearly Doubled Response Rate, So Why Did the Stock Fall?
Insider Monkey · 1h ago
Merck Has Two Overlooked Pipeline Catalysts Coming Before Year-End, UBS Says
MT Newswires · 1h ago
Can Recent Traction With Key Drugs and Pipeline Progress Boost BMY?
Zacks · 2h ago
How a Roth IRA Can Keep Thousands More of Your DJIA Dividend Income Compounding
24/7 Wall St. · 2h ago
Could Zanzalintinib's FDA Delay Affect Exelixis' Growth Plans?
Zacks · 3h ago

Headlines from Yahoo Finance. Not investment advice.

About

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).

Industry: Healthcare
CEO: Robert Davis